John Parry
- Virology top 0.5%
- HIV Research and Treatment 38
- Hepatology top 0.5%
- Hepatitis C virus research 25
- Hepatitis Viruses Studies and Epidemiology 8
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 39
- HIV/AIDS drug development and treatment 14
- Epidemiology top 0.5%
- HIV, Drug Use, Sexual Risk 40
- Hepatitis B Virus Studies 23
- Toxicology top 2%
-
- Blood groups and transfusion 10
John Parry
112 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 142
- Virology 972
- Hepatology 994
- Infectious Diseases 2.1k
- Epidemiology 2.6k
- Toxicology 91
Countries citing papers authored by John Parry
This map shows the geographic impact of John Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Parry more than expected).
Fields of papers citing papers by John Parry
This network shows the impact of papers produced by John Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Parry. The network helps show where John Parry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Parry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2017 | 16 | |
| 3 | 2015 | 33 | |
| 4 | 2011 | 231 | |
| 5 | 2010 | 82 | |
| 6 | 2008 | 71 | |
| 7 | 2007 | 22 | |
| 8 | 2007 | 6 | |
| 9 | 2007 | 83 | |
| 10 | 2004 | 54 | |
| 11 | 2003 | 2 | |
| 12 | Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. | 1999 | 24 |
| 13 | 1999 | 7 | |
| 14 | The risk of hepatitis A from sewage contamination of a water supply. | 1995 | 7 |
| 15 | 1995 | 19 | |
| 16 | 1994 | 75 | |
| 17 | 1994 | 52 | |
| 18 | Detection of HIV-1 antibodies in blood specimens spotted on filter-paper. | 1992 | 11 |
| 19 | 1988 | 82 | |
| 20 | Status report on Urenco's progress and plans | 1982 | 1 |
About John Parry
John Parry is a scholar working on Virology, Hepatology, Infectious Diseases, Epidemiology and Toxicology, having authored 114 papers that have together received 4.3k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (40 papers), HIV/AIDS Research and Interventions (39 papers), HIV Research and Treatment (38 papers), Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (23 papers), HIV/AIDS drug development and treatment (14 papers), Blood groups and transfusion (10 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). The work is most often cited by research in Virology (972 citations), Hepatology (994 citations), Infectious Diseases (2.1k citations), Epidemiology (2.6k citations) and Toxicology (91 citations). John Parry has collaborated with scholars based in United Kingdom, Maldives and United States. Frequent co-authors include Philip P. Mortimer, P P Mortimer, Vivian Hope, Matthew Hickman, Margaret Johnson, Fortune Ncube, Gary Murphy, Keith R. Perry, Tim Rhodes and Jonathan P. Clewley. Their work appears in journals such as AIDS, Journal of Medical Virology, Sexually Transmitted Infections, Journal of Clinical Microbiology and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.